Загрузка...
De-escalated Therapy Omitting Anthracyclines for Stage I HER2-positive Breast Cancer: A Retrospective Observational Study
Background: It is unclear whether the de-escalated therapy that omits anthracycline-based chemotherapy is as beneficial as standard therapy for patients with stage I human epidermal growth factor receptor 2-positive (HER2(+)) early breast cancer. Patients and Methods: We retrospectively investigated...
Сохранить в:
| Опубликовано в: : | In Vivo |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
International Institute of Anticancer Research
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7811635/ https://ncbi.nlm.nih.gov/pubmed/33144488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12219 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|